Prof. Dr. Daniel Dietrich

For the good of science

Human health impact and cost estimates attributed to endocrine disrupting chemicals are unfounded, say toxicologist Daniel Dietrich and epidemiologist Gregory G. Bond in the scientific journal "Archives of Toxicology".

A series of economic papers released in 2015 and 2016 estimated the burden of diseases attributable to exposure to endocrine disrupting chemicals (EDCs), also known as environmental estrogens, and associated costs in the US and EU. Many experts suspected right away that these calculations were flawed and thus immaterial to public health decision-making. A thorough critique of the underlying methodology used to generate the cost estimates was published in the influential peer-reviewed journal “Archives of Toxicology” this month.

The critical review comes at a time in which regulatory bodies on both sides of the Atlantic are moving forward with two relatively distinct approaches to identifying and regulating EDCs. The critique of the economic analyses, co-authored by Michigan-based epidemiologist Gregory G. Bond, Ph.D., Michigan (U.S.), and toxicologist Professor Daniel R. Dietrich, Ph.D., University of Konstanz, affirms widely held suspicions by members of the European Commission, U.S. and EU-based academics and science journalists who had publicly expressed concern over the validity of the cost estimates before. Read more...